Company Long-Term Loans and Borrowings: Grifols Group (GRFS)

Public company logo of Grifols SA (GRFS)

The GURU.Markets service features a line chart illustrating the status of long-term loans and borrowings of Grifols, S.A. (GRFS), where 3.39 is recorded as the baseline value. This trend reflects the debt leverage and the cost of plasma procurement. Growth relies on partnerships with government healthcare agencies for protein production, as well as the environmental modernization of plants to reduce water consumption and implement renewable energy.

GRFS Grifols, S.A. Company Long-Term Debts (07/04/2022 - 10/29/2026)

Grifols Group (GRFS) - metric breakdowns and financial figures

- market price and analyst price targets:
Stock Price grifols.com|GRFS - Price Target Chart
- company stock exchange capitalization indicators:
Market Value Grifols|GRFS - Total Company Value
- book capitalization information:
Accounting Value per Share Grifols|GRFS - Book Capitalization|Market Capitalization to Book Value Ratio grifols.com|GRFS - Cumulative Company Assets
- debt level and financial liquidity data:
All Debt to Shareholders' Equity Ratio Grifols, S.A.|GRFS - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Grifols Biemat|GRFS - Company Debts|Debt to Book Value Grifols|GRFS - Company Long-Term Debt|Company Current Liabilities Grifols|Quick Ratio grifols.com
- earnings and multiples data:
GRFS - Company Net Income
Analysis of all company metrics:GRFS - grifols.com
Brand item of Grifols, S.A.

To minimize risks when building a position, it is essential to monitor total multi-year liabilities, where the organization's long-term loans and borrowings aggregate all borrowed funds to eliminate quarterly gaps and assess leverage. Amidst the management restructuring at Grifols, S.A. (GRFS), the trend of this indicator determines the business's ability to restore market confidence and ensure financial stability without overheating the balance sheet.

Competitors of Grifols, S.A. (GRFS)

Company Long-Term Debts argenx.com ARGX|BNTX - Company Long-Term Debt|Company Long-Term Loans and Borrowings ABVX (abivax.com)|ADMA Bio (ADMA) - Company Long-Term Debt|Company Long-Term Liabilities Protagonist Corp|IMVT (Immunovant, Inc.) - Company Long-Term Debts|Company Long-Term Debts kiniksa.com|Company Long-Term Liabilities ADPT (Adaptive Biotechnologies Corporation)|CLDX (Celldex Therapeutics Inc) - Company Long-Term Loans and Borrowings|Company Long-Term Debts AUPH (Aurinia Pharma)|Long-Term Debt Volume BioCryst Corp (BCRX)|VERA - Company Long-Term Debt|dianthustx.com (DNTH) - Company Long-Term Liabilities|Pharvaris (PHVS) - Company Long-Term Debt|Company Long-Term Liabilities AbCellera Bio|Company Long-Term Liabilities TRML|Company Long-Term Debts Precigen Corp|Company Long-Term Debt Pharming Group N.V. (PHAR)|nektar.com - Company Long-Term Indebtedness|Company Long-Term Debts UPB (Upstream Bio)|Zenas Bio (ZBIO) - Long-Term Debt|Immunome Corp - Company Long-Term Debts|Long-Term Indebtedness Gossamer Bio Corp. (GOSS)|KalVista Pharmaceuticals (KALV) - Company Long-Term Debt|septerna.com - Company Long-Term Loans and Borrowings|PVLA (Pieris Pharmaceuticals, Inc.) - Company Long-Term Debts|Savara Inc (SVRA) - Long-Term Debt Volume|Company Long-Term Debts RIGL|ANAB: Long-Term Liabilities|Company Long-Term Debt Astria Therapeutics ATXS|engene.com (ENGN) - Long-Term Debt|RAPT - Company Long-Term Debt|JBIO: Company Long-Term Debt|Aclaris (ACRS) - Company Long-Term Debt|KYTX - Long-Term Debt Volume|Company Long-Term Liabilities TLSA|CABA: Company Long-Term Loans and Borrowings|Company Long-Term Debt Ventyx Biosciences, Inc. (VTYX)|Long-Term Debt Volume Theratechnologies, Inc.|Avalo Therapeutics Inc. - Company Long-Term Liabilities|Long-Term Debt Volume Eledon Pharmaceuticals, Inc (ELDN)|Agenus - Company Long-Term Debts|CLYM - Company Long-Term Debts|ZURA (Zura Bio Limited) - Company Long-Term Liabilities|ATYR - Long-Term Debt Volume|ADAG (Adagene Inc) - Company Long-Term Debts|IMA - Long-Term Indebtedness|Company Long-Term Debt Shattuck Labs, Inc. (STTK)|EQ (equilliumbio.com) - Company Long-Term Loans and Borrowings|Company Long-Term Debts CNTB (Connect Biopharma Holdings Limited)|IMUX (Immunic Therapeutics) - Long-Term Liabilities|ATRA - Company Long-Term Debt|Long-Term Debt Volume InflaRx N.V. IFRX|X4 Pharmaceuticals (XFOR) - Company Long-Term Debt|Long-Term Liabilities ACET (Adicet Bio, Inc.)|CELU (Celularity Inc) - Company Long-Term Debts|INMB: Company Long-Term Loans and Borrowings|Company Long-Term Debts BRNS|Company Long-Term Debts Kezar Life Sciences Inc (KZR)|Company Long-Term Debt SAB Biotherapeutics SABS|Company Long-Term Loans and Borrowings AKTX|ENLV - Company Long-Term Debt|Q32 Bio Inc. (QTTB) - Company Long-Term Liabilities|GOVX: Company Long-Term Debts|Edesa Biotech Corp (EDSA) - Company Long-Term Debts|Company Long-Term Liabilities IBIO|CARM: Company Long-Term Loans and Borrowings|Company Long-Term Debts XTLB|Long-Term Debt Volume boltbio.com|Company Long-Term Debt HCW Biologics HCWB|APVO - Company Long-Term Liabilities|AIM - Company Long-Term Debt|Aditxt (ADTX) - Company Long-Term Liabilities|GRI (GRI Bio) - Company Long-Term Liabilities|XORTX Therapeutics Inc (XRTX) - Company Long-Term Debts|Company Long-Term Debt ReShape Lifesciences|Company Long-Term Indebtedness REVB (Revelation Biosciences Corp)|Company Long-Term Debts INDP|SCNI - Long-Term Debt|Company Long-Term Debts CALI (CalciMedica)|Long-Term Indebtedness Affimed NV|ALLK - Company Long-Term Debt|Company Long-Term Loans and Borrowings HOOK (HOOKIPA Pharma Inc.)|IGMS: Company Long-Term Debts|ITOS - Long-Term Debt Volume|OCEA (Ocean Biomedical) - Company Long-Term Debts|TC BioPharm (Holdings) Plc - Long-Term Liabilities|Company Long-Term Debt Third Harmonic Bio, Inc (THRD)